adicetbio.com (ACET) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The growth in Adicet Bio (ACET) value is driven by successes in developing universal cell therapies to combat lymphomas, which is attracting capital. Operating within a protected US legal framework eliminates the impact of trade conflicts. This historical price chart for the EV/EBITDA metric is currently at 0.00. The business relies on innovative receptors for solid tumor therapy, bypassing industry patent barriers through a unique method of action.
adicetbio.com - analytical breakdowns and key metrics (ACET)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ACET - Net Financial Result|Projected Future Earnings Adicet Bio|ACET - Price to Earnings Ratio|Forward P/E Multiple Adicet Bio, Inc.|ACET - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Adicet Bio, Inc.|ACET - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months Adicet Bio|ACET - Earnings per share for the trailing year|Quarterly EPS earnings growth adicetbio.com|ACET - Earnings per share growth in current year|Earnings growth forecast for next year Adicet Bio
Initial company analysis:Adicet ACET
High bioreactor utilization and the optimal condition of Adicet Bio (ACET) production facilities establish the foundation for generating operating cash flow. By analyzing the EV/EBITDA multiple adjusted for net debt, an investor compares the total enterprise value, including debt, against earnings before interest, taxes, depreciation, and amortization, which enables an assessment of capital-intensive asset efficiency relative to the market consensus and helps avoid value traps.
Competitors of Adicet Bio
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|PHVS: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation ABCL|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Precigen Inc (PGEN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple PHAR|Enterprise Value to EBITDA Ratio Nektar Corp NKTR|EV/EBITDA Multiple UPB (Upstream Bio Inc)|zenasbio.com (ZBIO) - Company Value to EBITDA|IMNM: Enterprise Value to EBITDA Ratio|Gossamer Bio Inc - Enterprise Value to Operating Income Before Depreciation Ratio|KALV (KalVista Pharmaceuticals Inc) - Enterprise Value to EBITDA Ratio|Septerna Pharma - Business Value to Operating Income Before Depreciation|PVLA (Pieris Pharmaceuticals) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SVRA|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|enGene Corp (ENGN) - Company Value to EBITDA|RAPT Therapeutics - EV/EBITDA Multiple|JBIO - EV/EBITDA Multiple|ACRS: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Kyverna Therapeutics Inc.|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|Company Value to EBITDA Cabaletta Bio Inc CABA|Enterprise Value to EBITDA Ratio VTYX (Ventyx Biosciences)|Enterprise Value to Operating Income Before Depreciation Ratio THTX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|ELDN (Eledon Pharmaceuticals Inc.) - Company Value to Operating Income Before Depreciation Ratio|Agenus Inc - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation CLYM (Climb Bio, Inc)|ZURA: EV/EBITDA Multiple|atyrpharma.com (ATYR) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adagene Inc|IMA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Shattuck Labs, Inc. (STTK)|Enterprise Value to EBITDA Ratio equilliumbio.com EQ|EV/EBITDA Multiple CNTB (Connect Biopharma Holdings Limited)|EV/EBITDA Multiple Immunic Therapeutics IMUX|ATRA: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation IFRX (InflaRx N.V.)|XFOR: EV/EBITDA Multiple|CELU - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INmune Bio, Inc.|Enterprise Value to EBITDA Ratio barinthusbio.com (BRNS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Kezar Life Sciences, Inc. (KZR)|Enterprise Value to EBITDA Ratio SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Enlivex Therapeutics Ltd ENLV|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GOVX (geovax.com) - Enterprise Value to Operating Income Before Depreciation|EDSA: EV/EBITDA Multiple|Company Value to EBITDA iBio Inc (IBIO)|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple XTL Bio|EV/EBITDA Multiple BOLT|hcwbiologics.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|Total Company Value to Operating Income Before Depreciation Ratio aimimmuno.com (AIM)|Aditxt Corp - EV/EBITDA Multiple|GRI Bio Corporation (GRI) - Enterprise Value to EBITDA Ratio|XRTX: EV/EBITDA Multiple|Company Value to EBITDA reshapelifesciences.com (HIND)|Enterprise Value to EBITDA Ratio REVB|INDP (Indaptus Therapeutics Inc) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SCNI (Scinai)|CALI (calcimedica.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AFMD (Affimed N.V.)|Allakos Inc - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HOOKIPA - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Ocean Biomedical Corp (OCEA)|TCBP (TC Biopharm) - EV/EBITDA Multiple|EV/EBITDA Multiple thirdharmonicbio.com
